Food and Drugs Board warns public against unregistered, substandard Oxytocin Injection

The Food and Drugs Board (FDB) on Tuesday alerted the public of the presence of an unregistered and substandard Oxytocin Injection on the Ghanaian market.

It is used to induce labour and prevent or control excessive bleeding in women after delivery.

The said Oxytocin Injection, manufactured in China by Sinochem Ningbo Limited and imported into the country by the management of Daamas Company Limited, has the Batch Number: 101011, Manufacturing Date of 10/2010 and Expiry Date of 10/2013.

In a release signed by Dr Stephen Opuni, Chief Executive of FDB in Accra said laboratory analysis had confirmed that the product did not meet the quality requirements with regard to the active ingredients.

It said preliminary investigations by the Board revealed that management of Daamas Company Limited claimed the substandard Oxytocin Injection was supplied by a Nigerian but it was unable to disclose the identity of the so-called Nigerian.

Meanwhile, an official from Daamas Company Limited has been arrested by the Police and is helping in investigations, the release noted.

It advised hospitals, clinics, maternity homes and pharmacies to desist from buying and stocking the unregistered and substandard Oxytocin Injection.

The release said the Board would endeavour to execute its mandate to protect public health and safety at all times.

Source: GNA